Patient vulnerability associated with acute kidney injury after pulsed field ablation: A role for baseline biomarkers and haptoglobin phenotype
Heart Rhythm · 2026-09 · 23 (9) · e1907-e1915
DOI: 10.1016/j.hrthm.2026.04.028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Heart Rhythm, 2026-09. Verfasst von Kazumasa Suga und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Japan Community Healthcare Organization Chukyo Hospital, Nagoya, Japan. Electronic address: kazumasa.suga@gmail.com. Hauptthemen laut MEDLINE: Acute Kidney Injury, Haptoglobins, Atrial Fibrillation, Catheter Ablation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Excessive pulsed field ablation (PFA) applications for atrial fibrillation (AF) have been associated with hemolysis-related acute kidney injury (AKI); however, severe AKI can occur when application counts remain within conventional practice ranges. OBJECTIVE: In this study, we investigated baseline patient characteristics associated with postprocedural AKI development after PFA for AF. METHODS: Consecutive patients with AF who underwent PFA with a circular-array or pentaspline catheter were prospectively enrolled. AKI was defined as a serum creatinine increase of ≥0.3 mg/dL or ≥1.5 times baseline. We assessed whether patient characteristics, procedural factors, and periprocedural biomarkers (free plasma hemoglobin, haptoglobin, lactate dehydrogenase [LDH], and indirect bilirubin) were associated with AKI occurrence. RESULTS: Of 216 patients who underwent PFA (median 54 applications [interquartile range 44-67]), AKI occurred in 7 (3.2%); all events were classified as Kidney Disease: Improving Global Outcomes stage 1 and resolved within 1 month. Compared with the non-AKI group, the AKI group had lower estimated glomerular filtration rate (43.8 [39.2-48.5] vs 59.7 [49.3-70.3] mL/min/1.73 m2; P = .026), lower haptoglobin (39.0 [31.5-74.5] vs 90.0 [57.0-122.0] mg/dL; P = .020), and higher LDH (271.0 [223.0-304.5] vs 186.0 [168.0-209.0] IU/L; P < .001) at baseline. All AKI events occurred in patients with the haptoglobin 2-2 phenotype, an exploratory finding. Procedural factors and postprocedural changes in hemolysis-related biomarkers did not differ between groups. CONCLUSION: Baseline reduced estimated glomerular filtration rate, low haptoglobin, and elevated LDH were associated with postprocedural AKI, suggesting that patient vulnerability contributes to AKI after PFA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Japan Community Healthcare Organization Chukyo Hospital, Nagoya, Japan. Electronic address: kazumasa.suga@gmail.com.
- Department of Cardiology, Japan Community Healthcare Organization Chukyo Hospital, Nagoya, Japan.
- Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Zitieren
APA
Suga, K., Kato, H., Yamazaki, K., Sakurai, T., Yamazoe, S., Tsuzuki, K., Ota, T., Murakami, H., Kada, K., Tsuboi, N., Yanagisawa, S., Inden, Y., & Murohara, T. (2026). Patient vulnerability associated with acute kidney injury after pulsed field ablation: A role for baseline biomarkers and haptoglobin phenotype. Heart Rhythm, 23(9), e1907-e1915. https://doi.org/10.1016/j.hrthm.2026.04.028
Vancouver
Suga K, Kato H, Yamazaki K, Sakurai T, Yamazoe S, Tsuzuki K, et al. Patient vulnerability associated with acute kidney injury after pulsed field ablation: A role for baseline biomarkers and haptoglobin phenotype. Heart Rhythm. 2026;23(9):e1907-e1915. doi:10.1016/j.hrthm.2026.04.028
BibTeX
@article{Suga2026,
author = {Suga, Kazumasa and Kato, Hiroyuki and Yamazaki, Kodai and Sakurai, Taku and Yamazoe, Shinji and Tsuzuki, Kazuhito and Ota, Tomoyuki and Murakami, Hisashi and Kada, Kenji and Tsuboi, Naoya and Yanagisawa, Satoshi and Inden, Yasuya and Murohara, Toyoaki},
title = {Patient vulnerability associated with acute kidney injury after pulsed field ablation: A role for baseline biomarkers and haptoglobin phenotype},
journal = {Heart Rhythm},
year = {2026},
volume = {23},
number = {9},
pages = {e1907--e1915},
doi = {10.1016/j.hrthm.2026.04.028}
}
EUVIMED